Atomera(US:ATOM)2020-03-13 20:09Financial Performance - Revenue for the year ended December 31, 2019 was approximately $533,000, an increase from $246,000 in 2018, representing a growth of 116.3%[120] - Cost of revenue for 2019 was approximately $253,000, up from $148,000 in 2018, indicating a rise of 70.3%[121] - Operating expenses totaled approximately $13.9 million for 2019, compared to $13.2 million in 2018, reflecting an increase of 5.3%[122] - The net loss for the year ended December 31, 2019 was approximately $13.3 million, compared to a net loss of approximately $12.9 million in 2018[131] Expenses Breakdown - Research and development expenses for 2019 were approximately $7.7 million, an increase of 6% from $7.3 million in 2018[124] - General and administrative expenses rose to approximately $5.2 million in 2019, up 5% from $5.0 million in 2018[125] Cash Position - As of December 31, 2019, cash and cash equivalents were approximately $14.9 million, with working capital of approximately $13.5 million[131] - Net cash used in operating activities for 2019 was approximately $10.4 million, primarily due to the net loss adjusted for stock-based compensation[134] Future Outlook - The company anticipates increased fees from license agreements and royalties as it enters into manufacturing and distribution license agreements[118] - Future capital requirements will depend on the successful commercialization of technology and potential collaborations or acquisitions[133]